Orexigen Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.04.18	XYZprinting Presents New Ultrafast Stereolithography 3D Printer Powered by Nexa3D at Rapid + TCT 2018 (PR Newswire)
02.04.18	Ball to Announce First Quarter Earnings on May 3, 2018 (PR Newswire)
01.12.17	Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure (PR Newswire)
24.08.17	As Harvey Makes His Way to the Texas Coast Farmers Insurance® Gets Ready to Help (PR Newswire)
10.08.17	BioLife Solutions Announces Second Quarter 2017 Financial Results (PR Newswire)
25.02.17	Gainers & Losers Of The Day: CEMP, IPCI, OREX, RNVA, ARGS... (RTTNews)
08.02.17	Gainers & Losers Of The Day: EYES, SGNL, NEOT, DMTX, MBRX... (RTTNews)
07.02.17	Orexigen Therapeutics to Speak at Upcoming Investor Conferences (PR Newswire)
31.01.17	Drug Makers Stocks on Investors' Radar -- Depomed, United Therapeutics, DURECT, and Orexigen Therapeutics (PR Newswire)
25.01.17	Orexigen Therapeutics Announces Spanish Launch of Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Partnership with Laboratorios Farmacéuticos Rovi, S.A. (PR Newswire)
06.01.17	Orexigen Therapeutics Announces Publication of Contrave® (naltrexone HCl and bupropion HCl extended-release tablets) Real-World Study Results in "Obesity" (PR Newswire)
05.01.17	Orexigen Therapeutics Highlights Key Business Priorities for 2017 (PR Newswire)
05.01.17	Surges & Plunges - EVOK, OREX, MRUS, IMGN, AGRX (RTTNews)
04.01.17	Orexigen Therapeutics Launches "Brains Behind Weight Loss," a Dynamic Patient Focused Campaign to Educate Consumers on the Role of the Brain in Weight Loss (PR Newswire)
08.12.16	Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Consilient Health Ltd. for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in the UK and Ireland (PR Newswire)
11.07.16	Echo Fails The Test, OREX To Effect Reverse Split, PFE's S-TRAC Study Hits Goal (RTTNews)
02.05.16	Orexigen: S. Korea Oks Contrave Monotherapy For Weight Management In Overweight (RTTNews)
05.06.15	Orexigen, Takeda File Infringement Lawsuit Against Actavis (RTTNews)
22.12.14	JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice (RTTNews)
19.12.14	Orexigen: Mysimba Receives Positive CHMP Opinion Recommending Approval In EU (RTTNews)
10.11.14	Orexigen Therapeutics Turns To Profit In Q3 - Quick Facts (RTTNews)
21.10.14	NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal (RTTNews)
11.09.14	FDA Okays Orexigen Therapeutics' Weight-Loss Drug Contrave (RTTNews)
12.03.14	Orexigen Therapeutics Q4 Loss Narrows (RTTNews)
08.01.14	CGEN Plans Busy Year, CytoDyn Gets Going, OREX Gets FDA Date, DRRX On A High (RTTNews)
03.12.13	Orexigen Prices Offering Of $100 Mln Of Convertible Senior Notes Due 2020 (RTTNews)
25.11.13	Pre-market Movers For Nov 25 (WMT, OREX, CAMT, BBRY, CLDX) (RTTNews)
25.11.13	Orexigen's Contrave Light Study Meets Specified Criteria - Quick Facts (RTTNews)
25.11.13	AMGN, GSK Get FDA Nod, CLDX Walks The Talk, OREX Awaits Light, CELG On A High (RTTNews)
21.10.13	Pre-Market Review: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc. (PR Newswire)
04.10.13	AMRN Faces FDA Panel On Oct.16, Isis Pockets $2Mln, NEOG Effects Stock Split (RTTNews)
03.10.13	Orexigen Therapeutics Submits Contrave Marketing Authorization Application to European Medicines Agency (PR Newswire)
03.10.13	Orexigen Therapeutics Submits Contrave Marketing Authorization Application to European Medicines Agency (PR Newswire)
24.09.13	Morning Research: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc. (PR Newswire)
06.09.13	Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference (PR Newswire)
27.08.13	Orexigen Therapeutics Prepares for the Light Study Interim Analysis Based on Direction from Data Monitoring Committee (PR Newswire)
16.08.13	Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc. (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Orexigen Therapeutics IncShs

Aktien Top/Flop

Meistgelesene Nachrichten